Concepts (256)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nanoparticles | 13 | 2023 | 294 | 3.740 |
Why?
|
| beta-Glucans | 5 | 2023 | 10 | 3.710 |
Why?
|
| Ionic Liquids | 4 | 2023 | 16 | 3.280 |
Why?
|
| Graphite | 9 | 2023 | 50 | 3.150 |
Why?
|
| Drug Delivery Systems | 11 | 2023 | 182 | 2.380 |
Why?
|
| Antineoplastic Agents | 6 | 2023 | 756 | 2.260 |
Why?
|
| Neoplasms | 7 | 2023 | 1033 | 2.110 |
Why?
|
| Quantum Dots | 10 | 2017 | 26 | 2.060 |
Why?
|
| Melanoma | 2 | 2023 | 91 | 1.670 |
Why?
|
| Stomach Neoplasms | 2 | 2023 | 192 | 1.630 |
Why?
|
| Nanostructures | 5 | 2023 | 133 | 1.540 |
Why?
|
| Diagnostic Imaging | 5 | 2014 | 53 | 1.510 |
Why?
|
| Exosomes | 2 | 2022 | 97 | 1.460 |
Why?
|
| Pulmonary Fibrosis | 2 | 2023 | 25 | 1.180 |
Why?
|
| Phototherapy | 4 | 2023 | 19 | 1.150 |
Why?
|
| Photochemotherapy | 3 | 2023 | 37 | 1.150 |
Why?
|
| Mice | 20 | 2023 | 5668 | 1.120 |
Why?
|
| Biocompatible Materials | 3 | 2023 | 75 | 1.040 |
Why?
|
| Animals | 25 | 2023 | 14307 | 1.030 |
Why?
|
| Obesity | 3 | 2022 | 965 | 1.020 |
Why?
|
| Biosensing Techniques | 3 | 2023 | 81 | 1.010 |
Why?
|
| Drug Carriers | 7 | 2023 | 121 | 1.000 |
Why?
|
| Biomimetic Materials | 1 | 2023 | 23 | 0.920 |
Why?
|
| Angiotensins | 1 | 2022 | 6 | 0.910 |
Why?
|
| Excipients | 1 | 2022 | 19 | 0.890 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2021 | 592 | 0.870 |
Why?
|
| Carbon | 5 | 2023 | 95 | 0.860 |
Why?
|
| Fatty Acids | 1 | 2023 | 118 | 0.860 |
Why?
|
| Iron | 1 | 2023 | 204 | 0.830 |
Why?
|
| Gene Transfer Techniques | 3 | 2022 | 43 | 0.830 |
Why?
|
| Transforming Growth Factor beta | 1 | 2022 | 183 | 0.800 |
Why?
|
| Leptin | 1 | 2022 | 115 | 0.800 |
Why?
|
| Humans | 36 | 2023 | 34853 | 0.790 |
Why?
|
| Biological Products | 1 | 2022 | 67 | 0.780 |
Why?
|
| Skin Neoplasms | 1 | 2022 | 151 | 0.760 |
Why?
|
| Pharmaceutical Preparations | 1 | 2021 | 74 | 0.730 |
Why?
|
| Boron Compounds | 2 | 2018 | 17 | 0.730 |
Why?
|
| Administration, Oral | 7 | 2022 | 212 | 0.710 |
Why?
|
| Lung Neoplasms | 1 | 2023 | 336 | 0.700 |
Why?
|
| Dietary Fats | 1 | 2019 | 115 | 0.690 |
Why?
|
| Liver Neoplasms | 1 | 2021 | 195 | 0.670 |
Why?
|
| Polyethylene Glycols | 5 | 2023 | 80 | 0.660 |
Why?
|
| Nanotechnology | 3 | 2023 | 150 | 0.650 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2017 | 9 | 0.630 |
Why?
|
| Luminescence | 2 | 2014 | 22 | 0.630 |
Why?
|
| DNA | 2 | 2018 | 549 | 0.630 |
Why?
|
| RNA, Small Interfering | 3 | 2023 | 391 | 0.600 |
Why?
|
| Spectroscopy, Near-Infrared | 3 | 2013 | 24 | 0.580 |
Why?
|
| Cell Line, Tumor | 9 | 2023 | 2128 | 0.580 |
Why?
|
| Micelles | 3 | 2014 | 31 | 0.520 |
Why?
|
| Fibrosis | 3 | 2023 | 146 | 0.490 |
Why?
|
| Administration, Cutaneous | 2 | 2023 | 38 | 0.460 |
Why?
|
| Gastrointestinal Tract | 3 | 2023 | 59 | 0.460 |
Why?
|
| Heparin | 3 | 2017 | 34 | 0.400 |
Why?
|
| Doxorubicin | 3 | 2022 | 80 | 0.380 |
Why?
|
| Infrared Rays | 1 | 2010 | 18 | 0.380 |
Why?
|
| Polymers | 3 | 2018 | 117 | 0.370 |
Why?
|
| Adipose Tissue | 2 | 2021 | 167 | 0.350 |
Why?
|
| Erythrocytes | 2 | 2018 | 107 | 0.290 |
Why?
|
| Surface Properties | 3 | 2016 | 121 | 0.280 |
Why?
|
| Mice, Inbred C57BL | 2 | 2023 | 1530 | 0.280 |
Why?
|
| Taurocholic Acid | 2 | 2017 | 7 | 0.280 |
Why?
|
| Light | 3 | 2023 | 180 | 0.280 |
Why?
|
| Water | 2 | 2021 | 283 | 0.270 |
Why?
|
| Photosensitizing Agents | 2 | 2015 | 47 | 0.250 |
Why?
|
| Bleomycin | 1 | 2023 | 18 | 0.240 |
Why?
|
| Lung | 2 | 2023 | 413 | 0.240 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2019 | 1534 | 0.240 |
Why?
|
| Rats | 2 | 2022 | 3261 | 0.240 |
Why?
|
| Ketones | 1 | 2023 | 17 | 0.240 |
Why?
|
| Cobalt | 1 | 2023 | 23 | 0.240 |
Why?
|
| Fluorouracil | 1 | 2023 | 32 | 0.230 |
Why?
|
| Docosahexaenoic Acids | 1 | 2023 | 18 | 0.230 |
Why?
|
| Glycerophospholipids | 1 | 2022 | 4 | 0.230 |
Why?
|
| Cell Line | 2 | 2017 | 1289 | 0.230 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2022 | 19 | 0.230 |
Why?
|
| Cell Survival | 7 | 2017 | 818 | 0.230 |
Why?
|
| Microscopy, Confocal | 2 | 2016 | 210 | 0.220 |
Why?
|
| Caprylates | 1 | 2022 | 6 | 0.220 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2022 | 27 | 0.220 |
Why?
|
| Bile Acids and Salts | 1 | 2022 | 31 | 0.220 |
Why?
|
| Intestinal Absorption | 2 | 2019 | 19 | 0.210 |
Why?
|
| RNA Interference | 1 | 2023 | 225 | 0.210 |
Why?
|
| Choline | 1 | 2022 | 57 | 0.210 |
Why?
|
| Collagen | 1 | 2022 | 162 | 0.210 |
Why?
|
| Colon | 1 | 2022 | 98 | 0.210 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2022 | 139 | 0.210 |
Why?
|
| Hydrogen Bonding | 1 | 2021 | 119 | 0.210 |
Why?
|
| Skin | 1 | 2022 | 173 | 0.200 |
Why?
|
| Hydroxychloroquine | 1 | 2021 | 15 | 0.200 |
Why?
|
| Respiration, Artificial | 1 | 2021 | 37 | 0.200 |
Why?
|
| Cell Communication | 1 | 2022 | 93 | 0.200 |
Why?
|
| Electrochemical Techniques | 1 | 2020 | 22 | 0.200 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2022 | 209 | 0.200 |
Why?
|
| Fullerenes | 1 | 2021 | 30 | 0.190 |
Why?
|
| Electricity | 1 | 2020 | 9 | 0.190 |
Why?
|
| Cell Cycle Proteins | 1 | 2022 | 220 | 0.190 |
Why?
|
| Nanotubes, Carbon | 1 | 2021 | 67 | 0.180 |
Why?
|
| Cytokines | 1 | 2023 | 569 | 0.180 |
Why?
|
| Ultrasonography | 1 | 2020 | 115 | 0.180 |
Why?
|
| Rheology | 2 | 2016 | 24 | 0.180 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2021 | 99 | 0.180 |
Why?
|
| Antiviral Agents | 1 | 2021 | 148 | 0.180 |
Why?
|
| Liver | 1 | 2022 | 447 | 0.180 |
Why?
|
| Particle Size | 4 | 2017 | 200 | 0.180 |
Why?
|
| Tissue Distribution | 3 | 2017 | 197 | 0.180 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 901 | 0.180 |
Why?
|
| Hyaluronic Acid | 2 | 2017 | 33 | 0.170 |
Why?
|
| Tissue Engineering | 2 | 2021 | 59 | 0.170 |
Why?
|
| Eating | 1 | 2020 | 152 | 0.170 |
Why?
|
| Quality of Life | 1 | 2022 | 459 | 0.160 |
Why?
|
| Peptides | 1 | 2021 | 308 | 0.160 |
Why?
|
| Polylysine | 1 | 2018 | 8 | 0.160 |
Why?
|
| Mice, Nude | 3 | 2013 | 323 | 0.160 |
Why?
|
| Blood Coagulation | 1 | 2018 | 22 | 0.160 |
Why?
|
| Metal Nanoparticles | 1 | 2020 | 180 | 0.160 |
Why?
|
| Transcription Factors | 1 | 2023 | 653 | 0.160 |
Why?
|
| Histamine | 1 | 2017 | 17 | 0.160 |
Why?
|
| Rats, Zucker | 1 | 2017 | 22 | 0.160 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 355 | 0.160 |
Why?
|
| Immune Tolerance | 1 | 2017 | 61 | 0.160 |
Why?
|
| Leukemia | 1 | 2017 | 54 | 0.150 |
Why?
|
| Antigens, Viral | 1 | 2017 | 42 | 0.150 |
Why?
|
| Plasmids | 1 | 2018 | 233 | 0.150 |
Why?
|
| Oligopeptides | 1 | 2017 | 97 | 0.150 |
Why?
|
| Heparin, Low-Molecular-Weight | 2 | 2013 | 7 | 0.140 |
Why?
|
| Hemoglobins | 1 | 2016 | 101 | 0.140 |
Why?
|
| Methacrylates | 1 | 2016 | 4 | 0.140 |
Why?
|
| Intestinal Mucosa | 1 | 2017 | 115 | 0.140 |
Why?
|
| Cross-Linking Reagents | 1 | 2016 | 48 | 0.140 |
Why?
|
| Deoxycholic Acid | 2 | 2012 | 10 | 0.140 |
Why?
|
| Chitosan | 1 | 2016 | 36 | 0.140 |
Why?
|
| Nanocapsules | 1 | 2015 | 16 | 0.130 |
Why?
|
| Neoplasms, Experimental | 1 | 2015 | 36 | 0.130 |
Why?
|
| Chlorophyll | 1 | 2015 | 22 | 0.130 |
Why?
|
| Cadmium Compounds | 2 | 2014 | 7 | 0.130 |
Why?
|
| Polyethylene Terephthalates | 1 | 2014 | 2 | 0.130 |
Why?
|
| Ferric Compounds | 1 | 2015 | 49 | 0.130 |
Why?
|
| Selenium Compounds | 2 | 2014 | 11 | 0.130 |
Why?
|
| Tin Compounds | 1 | 2014 | 3 | 0.130 |
Why?
|
| Polytetrafluoroethylene | 1 | 2014 | 6 | 0.130 |
Why?
|
| Solar Energy | 1 | 2014 | 9 | 0.130 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 1300 | 0.130 |
Why?
|
| Electrodes | 1 | 2014 | 43 | 0.130 |
Why?
|
| Enzymes | 1 | 2014 | 30 | 0.130 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2014 | 94 | 0.120 |
Why?
|
| Fluorescence | 2 | 2015 | 117 | 0.120 |
Why?
|
| Antibodies | 1 | 2014 | 135 | 0.120 |
Why?
|
| Biomedical Technology | 1 | 2013 | 9 | 0.120 |
Why?
|
| Luminescent Proteins | 1 | 2014 | 74 | 0.120 |
Why?
|
| Biomedical Engineering | 1 | 2013 | 5 | 0.120 |
Why?
|
| Diet | 1 | 2020 | 747 | 0.120 |
Why?
|
| Bivalvia | 1 | 2013 | 20 | 0.120 |
Why?
|
| Photochemistry | 1 | 2013 | 61 | 0.120 |
Why?
|
| Mitochondria | 1 | 2017 | 454 | 0.120 |
Why?
|
| Toxicity Tests | 1 | 2013 | 42 | 0.120 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2013 | 59 | 0.120 |
Why?
|
| Solubility | 1 | 2013 | 115 | 0.120 |
Why?
|
| Transplantation, Heterologous | 1 | 2013 | 87 | 0.120 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2013 | 242 | 0.110 |
Why?
|
| Taxoids | 1 | 2013 | 36 | 0.110 |
Why?
|
| Male | 4 | 2020 | 18870 | 0.110 |
Why?
|
| Dogs | 1 | 2013 | 138 | 0.110 |
Why?
|
| Gold | 1 | 2014 | 134 | 0.110 |
Why?
|
| Indoles | 1 | 2013 | 154 | 0.110 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 468 | 0.100 |
Why?
|
| Anticoagulants | 1 | 2012 | 97 | 0.100 |
Why?
|
| Tellurium | 1 | 2010 | 5 | 0.100 |
Why?
|
| Nanospheres | 1 | 2010 | 7 | 0.100 |
Why?
|
| Whole Body Imaging | 1 | 2010 | 25 | 0.100 |
Why?
|
| Polyglycolic Acid | 1 | 2010 | 35 | 0.100 |
Why?
|
| Polyesters | 1 | 2010 | 21 | 0.090 |
Why?
|
| Caco-2 Cells | 3 | 2017 | 48 | 0.090 |
Why?
|
| Lactic Acid | 1 | 2010 | 87 | 0.090 |
Why?
|
| Female | 6 | 2021 | 19873 | 0.090 |
Why?
|
| Cell Proliferation | 2 | 2014 | 1149 | 0.080 |
Why?
|
| Time Factors | 1 | 2013 | 1681 | 0.080 |
Why?
|
| Antibodies, Monoclonal | 1 | 2010 | 282 | 0.080 |
Why?
|
| Delayed-Action Preparations | 2 | 2020 | 57 | 0.080 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 2016 | 138 | 0.070 |
Why?
|
| Contrast Media | 2 | 2015 | 95 | 0.060 |
Why?
|
| Treatment Outcome | 2 | 2021 | 1349 | 0.060 |
Why?
|
| Ethers | 1 | 2023 | 19 | 0.060 |
Why?
|
| Reactive Oxygen Species | 2 | 2017 | 416 | 0.060 |
Why?
|
| Serum Response Factor | 1 | 2023 | 10 | 0.060 |
Why?
|
| Genes, Switch | 1 | 2022 | 3 | 0.060 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2022 | 9 | 0.060 |
Why?
|
| rho-Associated Kinases | 1 | 2023 | 30 | 0.060 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2022 | 117 | 0.050 |
Why?
|
| Immunization, Passive | 1 | 2021 | 18 | 0.050 |
Why?
|
| Onions | 1 | 2021 | 5 | 0.050 |
Why?
|
| Latin America | 1 | 2021 | 41 | 0.050 |
Why?
|
| Europe | 1 | 2021 | 88 | 0.050 |
Why?
|
| Asia | 1 | 2021 | 74 | 0.050 |
Why?
|
| Cesarean Section | 1 | 2021 | 53 | 0.050 |
Why?
|
| Iontophoresis | 1 | 2020 | 13 | 0.050 |
Why?
|
| Equipment Design | 1 | 2020 | 127 | 0.050 |
Why?
|
| Electroporation | 1 | 2020 | 18 | 0.050 |
Why?
|
| Pregnancy Outcome | 1 | 2021 | 90 | 0.050 |
Why?
|
| Disease Progression | 1 | 2022 | 580 | 0.050 |
Why?
|
| Premature Birth | 1 | 2021 | 71 | 0.050 |
Why?
|
| Length of Stay | 1 | 2021 | 184 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2023 | 562 | 0.040 |
Why?
|
| Blood-Brain Barrier | 1 | 2020 | 153 | 0.040 |
Why?
|
| Hemorheology | 1 | 2018 | 6 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2021 | 871 | 0.040 |
Why?
|
| Dihydroxyphenylalanine | 1 | 2017 | 8 | 0.040 |
Why?
|
| K562 Cells | 1 | 2017 | 31 | 0.040 |
Why?
|
| Vaccines, Conjugate | 1 | 2017 | 7 | 0.040 |
Why?
|
| Molecular Conformation | 1 | 2017 | 150 | 0.040 |
Why?
|
| Biological Transport | 1 | 2017 | 175 | 0.040 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2017 | 17 | 0.040 |
Why?
|
| Hep G2 Cells | 1 | 2017 | 52 | 0.040 |
Why?
|
| Apoptosis | 2 | 2015 | 1317 | 0.040 |
Why?
|
| Erythrocyte Deformability | 1 | 2016 | 1 | 0.040 |
Why?
|
| Hela Cells | 1 | 2018 | 344 | 0.040 |
Why?
|
| Vaccines | 1 | 2017 | 49 | 0.040 |
Why?
|
| Phase Transition | 1 | 2016 | 9 | 0.040 |
Why?
|
| Muramidase | 1 | 2016 | 18 | 0.040 |
Why?
|
| Chondrocytes | 1 | 2016 | 15 | 0.040 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2016 | 67 | 0.030 |
Why?
|
| Pregnancy | 1 | 2021 | 1503 | 0.030 |
Why?
|
| Hydrogels | 1 | 2016 | 33 | 0.030 |
Why?
|
| Polyethyleneimine | 1 | 2015 | 2 | 0.030 |
Why?
|
| Rabbits | 1 | 2016 | 278 | 0.030 |
Why?
|
| KB Cells | 1 | 2015 | 7 | 0.030 |
Why?
|
| Ultraviolet Rays | 1 | 2016 | 116 | 0.030 |
Why?
|
| Diffusion | 1 | 2015 | 49 | 0.030 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2015 | 41 | 0.030 |
Why?
|
| Chickens | 1 | 2016 | 123 | 0.030 |
Why?
|
| Temperature | 1 | 2016 | 275 | 0.030 |
Why?
|
| Adenosine | 1 | 2014 | 54 | 0.030 |
Why?
|
| Zinc Compounds | 1 | 2014 | 12 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2016 | 467 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2017 | 751 | 0.030 |
Why?
|
| Cell Death | 1 | 2015 | 260 | 0.030 |
Why?
|
| Sulfides | 1 | 2014 | 58 | 0.030 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2014 | 107 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 2014 | 181 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2013 | 79 | 0.030 |
Why?
|
| Glucose | 1 | 2014 | 217 | 0.030 |
Why?
|
| Mice, Hairless | 1 | 2012 | 8 | 0.030 |
Why?
|
| Ileum | 1 | 2012 | 15 | 0.030 |
Why?
|
| Biochemistry | 1 | 2012 | 12 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2014 | 376 | 0.030 |
Why?
|
| Scattering, Radiation | 1 | 2012 | 45 | 0.030 |
Why?
|
| Intestines | 1 | 2012 | 63 | 0.030 |
Why?
|
| Cadmium | 1 | 2012 | 56 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2012 | 143 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2014 | 649 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2012 | 342 | 0.030 |
Why?
|
| United States | 1 | 2021 | 3894 | 0.030 |
Why?
|
| Young Adult | 1 | 2021 | 4012 | 0.020 |
Why?
|
| Luminescent Measurements | 1 | 2010 | 26 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 984 | 0.020 |
Why?
|
| Adult | 1 | 2021 | 11034 | 0.020 |
Why?
|